Page last updated: 2024-11-11

synerazol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

synerazol: from Aspergillus fumigatus; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID11165858
CHEMBL ID473144
MeSH IDM0188237

Synonyms (3)

Synonym
synerazol
CHEMBL473144
(5s,8s,9r)-8-benzoyl-2-[(2s,3r)-3-[(z)-but-1-enyl]oxiran-2-yl]-9-hydroxy-8-methoxy-3-methyl-1-oxa-7-azaspiro[4.4]non-2-ene-4,6-dione
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (5)

Assay IDTitleYearJournalArticle
AID394967Inhibition of IL4 and LPS-induced IgE production in BALB/c mouse spleen B cell after 6 days by ELISA2009Bioorganic & medicinal chemistry letters, Mar-01, Volume: 19, Issue:5
Pseurotin A and its analogues as inhibitors of immunoglobulin E [correction of immunoglobuline E] production.
AID394968Immunosuppressive activity in rat lymphocytes assessed as inhibition of mixed-lymphocyte reaction2009Bioorganic & medicinal chemistry letters, Mar-01, Volume: 19, Issue:5
Pseurotin A and its analogues as inhibitors of immunoglobulin E [correction of immunoglobuline E] production.
AID394971Cytotoxicity against BALB/c mouse B cells assessed as cell viability2009Bioorganic & medicinal chemistry letters, Mar-01, Volume: 19, Issue:5
Pseurotin A and its analogues as inhibitors of immunoglobulin E [correction of immunoglobuline E] production.
AID394969Inhibition of PHA-induced BALB/c mouse T cell proliferation at 10 uM2009Bioorganic & medicinal chemistry letters, Mar-01, Volume: 19, Issue:5
Pseurotin A and its analogues as inhibitors of immunoglobulin E [correction of immunoglobuline E] production.
AID394970Cytotoxicity against human K562 cells2009Bioorganic & medicinal chemistry letters, Mar-01, Volume: 19, Issue:5
Pseurotin A and its analogues as inhibitors of immunoglobulin E [correction of immunoglobuline E] production.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's5 (83.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]